Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma. Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
We aimed to identify peripheral blood biomarkers that predict the response of advanced HCC to anti-PD-1 therapy. Overall design: Classical monocytes (CD11b+CD3−CD19−CD14+CD16− cells) were sorted from PBMCs collected at day0 and day7 from four patients with DCB and four patients with NDB.
创建时间：
2022-05-03
